|
TTYH3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.036400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.754170E-02 |
| Normal-vs-Stage2 |
2.559800E-01 |
| Normal-vs-Stage3 |
1.444980E-01 |
| Normal-vs-Stage4 |
3.693200E-01 |
| Stage1-vs-Stage2 |
7.037000E-01 |
| Stage1-vs-Stage3 |
5.770800E-01 |
| Stage1-vs-Stage4 |
3.655800E-01 |
| Stage2-vs-Stage3 |
9.773400E-01 |
| Stage2-vs-Stage4 |
7.183000E-01 |
| Stage3-vs-Stage4 |
6.966200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.260370E-02 |
| Normal-vs-AfricanAmerican |
1.412180E-01 |
| Normal-vs-Asian |
6.119600E-01 |
| Caucasian-vs-AfricanAmerican |
9.413600E-01 |
| Caucasian-vs-Asian |
5.031500E-02 |
| AfricanAmerican-vs-Asian |
2.576200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.903790E-02 |
| Normal-vs-Female |
6.860000E-02 |
| Male-vs-Female |
2.582200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.303500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.587810E-01 |
| Normal-vs-Age(61-80Yrs) |
1.717410E-01 |
| Normal-vs-Age(81-100Yrs) |
6.500000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.447800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.721600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.262400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.740800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.062790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.753900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.576000E-02 |
| Classical-VS-Follicular |
1.141570E-01 |
| Classical-VS-Other |
3.590000E-01 |
| Classical-VS-Normal |
6.436000E-03 |
| Tall-VS-Follicular |
5.021800E-01 |
| Tall-VS-Other |
8.739400E-01 |
| Tall-VS-Normal |
9.062200E-01 |
| Follicular-VS-Other |
6.821800E-01 |
| Follicular-VS-Normal |
3.883200E-01 |
| Other-VS-Normal |
9.329600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.638100E-02 |
| Normal-vs-N1 |
6.654300E-02 |
| N0-vs-N1 |
6.436400E-01 |
|
|
